Genmab — Februar 2019

[Hen]

Den nye version kan tages via sprøjte med en behandlingstid på bare omkring tre minutter, mens den nuværende version af Darzalex tages intravenøst over tre en halv time.
Aktien ligger torsdag yderligere 1,5 pct. højere i 1143 kr. og er over den seneste seks børsdage steget sammenlagt 13,4 pct.
/ritzau/FINANS

[E_L]

@Bulder yes, that is the big question. My guess is that we will have to wait for that data, but just as the data for Columba came so quick, I am now hoping for the additional data to also come quicker as expected.

[Vester]

@Bulder har du stillet spm til Winkel ang dette?

[E_L]

preliminary completion dates for Columba and MMY2040 are very similar, even though the latter started later

[E_L]

and we have been told a few times 'recruitment is going very fast'

[Bulder]

yes, I have a Q about this.

[E_L]

@Vester , this is what Jan said last Feb Q&A: Q: In january you started a “Study to evaluate Subcutaneous Daratumumab in
combination with Standard Multiple Myeloma Treatment Regimens”, which is a Phase
2. You already have the Phase 3 SC vs IV study; could these 2 clinical trials be the
basis for an overall approval of SC in all lines and settings?
Jan Van de Winkel: This is a good thought.

[E_L]

@Hen do you know if they changed their target price?

[Hen]

@
EL. Nej, desværre ikke.

[Sibelius]

Ser lige at Genmab havde 20 års fødselsdag forleden. Bekræfter det gamle mundheld om at selv de grimmeste børn kan komme til at se godt ud fuldt udvoksede:-)

[Vester]

thanks El, primary completion date for MMY2040 is even set to a month sooner than Columba.. Maybe that data will come sooner than expected as well

[henrik48]

@Hen...har de “hævet” til underperform eller outperform ?

[henrik48]

Undskyld...jeg har læst det forkert...beklager !

[Helge_LarsenPI-redaktør]

Hans-Henrik om Genmab: http://www.proinvestor.com/debat/76737

[Helge_LarsenPI-redaktør]

12-13 minutter inde i udsendelsen.

[polle1]

Tjaarh, han er ikke sådan rigtig "lun" endnu den gode Hans Henrik

[polle1]

Hov, der røg mit plus, jeg får lige
lavet en donation, Helge

[Helge_LarsenPI-redaktør]

Hans-Henrik overholder sin strategi. Det er fair nok. PS: Kan afsløre at han hungrer efter købssignalet efter brud
af 1.200.

[Helge_LarsenPI-redaktør]

[peter12]

Den norske oliefond har øget ca 0,5% procent i Genmab i 2018 (hvis jeg husker ret) ? https://www.nbim.no/en/the-fund/holdings/holdings-as-at-31.12.2018/?fullsize=true